Understand the source comparison
Best Peptides for Women 35-45: Research Comparison
BPC-157 VEGF upregulation, angiogenesis acceleration Tendon/ligament repair, gut healing, systemic anti-inflammatory 250–500 mcg daily Subcutaneous injection near injury site or systemic Gold standard for soft tissue recovery in perimenopause. Works independen
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- VEGF upregulation, angiogenesis acceleration
- Tendon/ligament repair, gut healing, systemic anti-inflammatory
- 250–500 mcg daily
- Subcutaneous injection near injury site or systemic
- Gold standard for soft tissue recovery in perimenopause. Works independently of estrogen status
- CJC-1295/Ipamorelin
- GHRH receptor agonism + ghrelin mimetic
- GH pulse restoration, lean mass retention, lipolysis
- CJC: 1–2 mg weekly; Ipamorelin: 200–300 mcg daily
- Subcutaneous injection
- Most effective GH secretagogue combination for women 35+. Synergistic without endogenous suppression
- Thymosin Beta-4
- Actin polymerization, fibroblast activation
- Collagen synthesis, wound healing, joint health
- 2–5 mg twice weekly
- Essential for collagen matrix repair when estrogen-mediated synthesis declines
- MOTS-c
- AMPK activation, mitochondrial biogenesis
- Insulin sensitivity, metabolic efficiency, exercise response
- 5–10 mg weekly
- Subcutaneous or intranasal
- Restores metabolic flexibility lost during perimenopause. Mimics exercise adaptation
- Selank
- GABAergic modulation, anxiolytic
- Stress response, anxiety reduction, sleep quality
- 250–500 mcg 1–2x daily
- Intranasal spray
- Non-sedating anxiolytic without tolerance. Addresses cortisol dysregulation
- Semax
- BDNF upregulation, dopaminergic enhancement
- Cognitive function, focus, neuroprotection
- 300–600 mcg 1–2x daily
- Compensates for estrogen-dependent cognitive decline through alternative neuroprotective pathways